NYSE$MAX

MediaAlpha Inc · Q4 2022 earnings

Q4 2022 earnings · · Investor relations

Briefing

Announced fourth quarter and full year 2022 financial results.

MediaAlpha's fourth quarter revenue was $124 million, a 23% decrease year-over-year. The results exceeded expectations, driven by strong carrier spend in the Health insurance vertical. The Property & Casualty insurance vertical continued to be negatively impacted.

  • Fourth quarter revenue was $124 million, down 23% year over year.
  • Fourth quarter Transaction Value was $169 million, down 31% year over year.
  • Fourth quarter Transaction Value from Property & Casualty was down 53% year over year to $57 million.
  • Fourth quarter Transaction Value from Health was flat year over year at $99 million.

Headline financials

Total Revenue

$124M

Previous: $162M-23.3%
EPS (adj)

-$0.63

Previous: -$0.10-530.0%
Transaction Value

$169M

Previous: $245M-31.0%
Gross Margin

16.2%

Previous: 15.7%+3.2%
Contribution Margin

18.5%

Previous: 16.6%+11.4%
Adjusted EBITDA

$9.04M

Previous: $13.2M-31.5%
Capital Expenditures

$98K

Previous: $650K-84.9%
Free Cash Flow

-$6.56M

Previous: $21.3M-130.8%
Net Income

-$28.4M

Previous: -$4M-608.8%
Operating Income

-$6.54M

Previous: $2.15M-404.1%
Gross Profit

$20.1M

Previous: $25.4M-20.7%
Cash & Equivalents

$14.5M

Previous: $50.6M-71.2%
Total Assets

$170M

Previous: $290M-41.3%
Stock-Based Comp

$14.3M

Previous: $12.4M+15.0%

Revenue & EPS history

MediaAlpha · Revenue · Quarterly

$124M

Q4 2022-23.3%vs Q4 2021
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Forward guidance

Guidance for Q1 2023 reflects typical seasonality along with an improvement in market conditions in P&C vertical compared with Q4 2022.

Tailwinds

  • P&C Transaction Value to nearly double in Q1 2023 compared with Q4 2022, indicative of both the early stages of recovery from the hard market and normal seasonality.
  • Transaction Value between $180 million - $195 million.
  • Revenue between $106 million - $116 million.
  • Adjusted EBITDA between $5.5 million - $7.5 million.
  • Cash operating expenses to be in line with Q4 2022.

Headwinds

  • Click pricing is expected to be down on a year-over-year basis.
  • In Health vertical, expect modest year-over-year growth in Transaction Value.
  • For the Life and Other verticals, expect Transaction Value to decline year over year at a similar rate as in Q4 2022.
  • P&C Transaction Value to be well below Q1 2022 levels.
  • Transaction Value represents a 22% year-over-year decline at the midpoint of the guidance range, driven primarily by P&C vertical.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q4 2022

Historical avgQ4 2022

+3.4%

Avg return

Earnings day

+1.5%

Avg return

5 days after

+0.5%

Avg return

30 days after

50%

11 / 22 earnings

Positive

+31.8%

Q3 2022

Best reaction

-18.5%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-0.1%-11.3%-11.8%
Q4 2025+12.3%+27.9%+23.4%
Q3 2025+10.8%+20.1%+14.7%
Q1 2025+14.2%+18.2%+21.4%
Q4 2024-18.5%-18.6%-11.0%
Q3 2024-12.6%-17.9%-35.5%
Q2 2024+15.0%+12.1%+23.4%
Q1 2024+9.0%+9.3%-12.2%
Q4 2023+22.3%+24.2%+26.0%
Q3 2023-4.6%-15.8%+0.1%
Q2 2023-3.0%-6.2%-13.2%
Q1 2023-2.4%-6.4%+50.7%
Q4 2022+12.3%+4.8%+1.0%
Q3 2022+31.8%+26.4%+2.3%
Q2 2022-15.0%-32.8%-28.9%
Q1 2022-9.6%-22.0%-31.2%
Q4 2021+28.9%+31.6%+39.1%
Q3 2021-1.5%+12.7%-2.1%
Q2 2021-6.6%-19.1%-25.2%
Q1 2021-13.1%-4.2%+3.6%
Q4 2020+3.3%+8.2%-30.3%
Q3 2020+1.8%-7.4%+7.2%
Q2 2020
Q1 2020
Q4 2019
Q3 2019
Q2 2019
Q1 2019
Q2 2018
Q1 2018

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro